|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 312.12 USD | -1.54% |
|
+6.21% | +2.74% |
| 07/05 | RBC Capital Adjusts BeOne Medicines PT to $425 From $423, Maintains Outperform Rating | MT |
| 07/05 | BeOne Medicines Shares Surge After Robust First-Quarter | DJ |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 47.3x | 6.95x | 4.79x | 31.64x | 37.72x | 3.47TCr | ||
| 1.11% | 1.27% | 29.29x | 3.52x | 5.17x | 16.01x | 22.48x | 4.34TCr | ||
| -.--% | -.--% | -17.93x | 13.02x | 275.37x | -16.05x | -16x | 3.01TCr | ||
| -.--% | -.--% | 21.76x | 4.12x | 2.53x | 10.94x | 16.72x | 2.98TCr | ||
| 0.39% | 0.42% | 31.98x | 2.36x | 8.16x | 20.99x | 25.22x | 2.85TCr | ||
| -.--% | -.--% | -21.32x | -3785.5x | 13.76x | -21.38x | -20.08x | 1.25TCr | ||
| 1.29% | 1.5% | 20.79x | 2.16x | 1.84x | 8.08x | 12.79x | 1.23TCr | ||
| -.--% | -.--% | 24.89x | 12.46x | 3.95x | 17.99x | 18.86x | 1.21TCr | ||
| -.--% | -.--% | -29.59x | 39x | 3023.46x | -33.13x | -29.61x | 983.29Cr | ||
| -.--% | -.--% | 19.55x | 1.01x | 1.52x | 7.82x | 8.62x | 950.6Cr | ||
| -.--% | -.--% | -22.05x | 8.22x | 3576.99x | -18.38x | -17.66x | 919.13Cr | ||
| -.--% | -.--% | -24.25x | 20.31x | 6.12x | 150.25x | -423.17x | 895.31Cr | ||
| -.--% | -.--% | 27.74x | 2.62x | 2.69x | 10.35x | 12.75x | 855.56Cr | ||
| 1.26% | 1.42% | 33.37x | 3.82x | 6.7x | 22.08x | 28.44x | 774.38Cr | ||
| 0.66% | 0.66% | 41.48x | 3.51x | 6.2x | 17.58x | 19.32x | 757.17Cr | ||
| -.--% | -.--% | -24.26x | 6.29x | 71.13x | -15.17x | -14.71x | 708.07Cr | ||
| -.--% | 0.57% | 15.43x | 1.81x | 3.31x | 9.13x | 11.28x | 683.27Cr | ||
| Average | 0.28% | 0.34% | 10.25x | -214.96x | 412.57x | 12.87x | -18.06x | 1.64TCr | |
| Weighted average by Cap. | 0.32% | 0.38% | 15.93x | -162.99x | 260.38x | 12.75x | -2.01x |
- Stock Market
- Equities
- ONC Stock
- Sector BeOne Medicines AG
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















